You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
McKinsey
Harvard Business School
Johnson and Johnson

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PBT-1033


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PBT-1033?

PBT-1033 is an investigational drug.

There have been 5 clinical trials for PBT-1033. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.

The most common disease conditions in clinical trials are Esophageal Neoplasms, Carcinoma, Non-Small-Cell Lung, and Acne Vulgaris. The leading clinical trial sponsors are Mayo Clinic, M.D. Anderson Cancer Center, and GlaxoSmithKline.

Recent Clinical Trials for PBT-1033
TitleSponsorPhase
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerNational Cancer Institute (NCI)Phase 3
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerNRG OncologyPhase 3
Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood TherapyxjpfWN/A

See all PBT-1033 clinical trials

Clinical Trial Summary for PBT-1033

Top disease conditions for PBT-1033
Top clinical trial sponsors for PBT-1033

See all PBT-1033 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Express Scripts
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.